Phillip Torralva
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$699KFederal grants as PI2 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $699K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 15, 2022 | NIH | SBIR Phase I Fentanyl induces naloxone-resistant vocal cord closure: target validation and development of opioid overdose treatments using a peer-reviewed animal model. | $324K | TORRALVA MEDICAL THERAPUETICS LLC |
| Sep 30, 2021 | NIH | STTR Phase I I-Corps Project plan for:STTR Phase I Development of therapeutics to treat fentanyl overdose using a validated animal model | $375K | TORRALVA MEDICAL THERAPUETICS LLC with OREGON HEALTH & SCIENCE UNIVERSITY |
Peer ranks
Federal funding#2,084
Awards as PI#1,252
Patents#273
Companies
- TORRALVA MEDICAL THERAPUETICS LLCLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.